Cargando…
Macrolides as Empiric Therapy for Outpatients With Pneumonia
Autor principal: | Musher, Daniel M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266641/ https://www.ncbi.nlm.nih.gov/pubmed/34250182 http://dx.doi.org/10.1093/ofid/ofab062 |
Ejemplares similares
-
Macrolides and community-acquired pneumonia: is quorum sensing the key?
por: Wise, Matt P, et al.
Publicado: (2010) -
Bacterial Coinfection in COVID-19 and Influenza Pneumonia
por: Musher, Daniel M.
Publicado: (2021) -
The Efficacy of Glucocorticoid on Macrolide Resistant Mycoplasma Pneumonia in Children
por: Oh, Jae-Won
Publicado: (2014) -
Additional corticosteroids or alternative antibiotics for the treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia
por: Yang, Eun-Ae, et al.
Publicado: (2017) -
Macrolide resistance in pneumococci—is it relevant?
por: Cheng, Allen C., et al.
Publicado: (2016)